DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,074 filers reported holding DANAHER CORPORATION in Q4 2022. The put-call ratio across all filers is 1.10 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $310,621 | +2.7% | 1,252 | -0.6% | 0.02% | +5.0% |
| Q2 2023 | $302,400 | -8.1% | 1,260 | -3.4% | 0.02% | -9.1% |
| Q1 2023 | $328,912 | -6.5% | 1,305 | -1.5% | 0.02% | -15.4% |
| Q4 2022 | $351,682 | -3.6% | 1,325 | -6.4% | 0.03% | -10.3% |
| Q3 2022 | $365,000 | +3.4% | 1,415 | +1.7% | 0.03% | +7.4% |
| Q2 2022 | $353,000 | -13.5% | 1,392 | 0.0% | 0.03% | +3.8% |
| Q1 2022 | $408,000 | -11.7% | 1,392 | -0.9% | 0.03% | -10.3% |
| Q4 2021 | $462,000 | +6.9% | 1,404 | -1.1% | 0.03% | +3.6% |
| Q3 2021 | $432,000 | -0.9% | 1,419 | -12.6% | 0.03% | -3.4% |
| Q2 2021 | $436,000 | -5.0% | 1,623 | -20.4% | 0.03% | -9.4% |
| Q1 2021 | $459,000 | -12.7% | 2,040 | -13.9% | 0.03% | -17.9% |
| Q4 2020 | $526,000 | +2.7% | 2,369 | -0.5% | 0.04% | -4.9% |
| Q3 2020 | $512,000 | +19.1% | 2,380 | -2.1% | 0.04% | +10.8% |
| Q2 2020 | $430,000 | +22.5% | 2,430 | -4.2% | 0.04% | +5.7% |
| Q1 2020 | $351,000 | -6.4% | 2,536 | +3.6% | 0.04% | +9.4% |
| Q4 2019 | $375,000 | +5.9% | 2,448 | 0.0% | 0.03% | 0.0% |
| Q3 2019 | $354,000 | -13.7% | 2,448 | -14.7% | 0.03% | -15.8% |
| Q2 2019 | $410,000 | +19.5% | 2,871 | +10.7% | 0.04% | +11.8% |
| Q1 2019 | $343,000 | +20.8% | 2,594 | -5.9% | 0.03% | +9.7% |
| Q4 2018 | $284,000 | -9.0% | 2,757 | -4.3% | 0.03% | 0.0% |
| Q3 2018 | $312,000 | +14.7% | 2,880 | +4.5% | 0.03% | +10.7% |
| Q2 2018 | $272,000 | +0.7% | 2,757 | 0.0% | 0.03% | 0.0% |
| Q1 2018 | $270,000 | +100.0% | 2,757 | +89.2% | 0.03% | +100.0% |
| Q4 2017 | $135,000 | -14.6% | 1,457 | -21.3% | 0.01% | -12.5% |
| Q3 2017 | $158,000 | -7.1% | 1,851 | -8.0% | 0.02% | -11.1% |
| Q2 2017 | $170,000 | +7.6% | 2,011 | +8.8% | 0.02% | +5.9% |
| Q1 2017 | $158,000 | +39.8% | 1,848 | +26.7% | 0.02% | +30.8% |
| Q4 2016 | $113,000 | -12.4% | 1,458 | -11.9% | 0.01% | -7.1% |
| Q3 2016 | $129,000 | -19.4% | 1,655 | +4.4% | 0.01% | -22.2% |
| Q2 2016 | $160,000 | +13.5% | 1,585 | +6.8% | 0.02% | +12.5% |
| Q1 2016 | $141,000 | +2.2% | 1,484 | 0.0% | 0.02% | 0.0% |
| Q4 2015 | $138,000 | -23.3% | 1,484 | -29.8% | 0.02% | -27.3% |
| Q3 2015 | $180,000 | -5.3% | 2,114 | -4.8% | 0.02% | 0.0% |
| Q2 2015 | $190,000 | +57.0% | 2,220 | +56.3% | 0.02% | +57.1% |
| Q1 2015 | $121,000 | 0.0% | 1,420 | 0.0% | 0.01% | +7.7% |
| Q4 2014 | $121,000 | +12.0% | 1,420 | 0.0% | 0.01% | +18.2% |
| Q3 2014 | $108,000 | -2.7% | 1,420 | 0.0% | 0.01% | -8.3% |
| Q2 2014 | $111,000 | +3.7% | 1,420 | 0.0% | 0.01% | 0.0% |
| Q1 2014 | $107,000 | -14.4% | 1,420 | -12.3% | 0.01% | -14.3% |
| Q4 2013 | $125,000 | +10.6% | 1,620 | 0.0% | 0.01% | 0.0% |
| Q3 2013 | $113,000 | +10.8% | 1,620 | 0.0% | 0.01% | +7.7% |
| Q2 2013 | $102,000 | – | 1,620 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |